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SUMMARY 
 
THE VALUE OF DYNAMIC CONTRAST-ENCHANCED COMPUTERIZED 
TOMOGRAPHY IN THE ASSESSMENT OF SOLITARY PULMONARY NODULES 
 
 
OBJECTIVE 
 The purpose of this study is to assess the value of dynamic contrast enhanced 
computerized tomography in the differential diagnosis of solitary pulmonary nodules.  
 
MATERIAL & METHOD 
 Thirty adult patients who had a solitary pulmonary nodule ranging between 1 – 3 cm 
on chest X-Ray were enrolled in this prospective study. The study was approved by the 
ethical committee of Adnan Menderes University. Patients were informed about the study and 
signed consent was obtained.  
 First of all; single breath-hold pre-contrast thorax CT examination was done with the 
following parameters: slice thickness: 7 mm, 120 kVp, 200 mAs, pitch: 1,5/1. The nodule was 
localized; diameter and the contour properties were noted. Then, the internal characteristics of 
the nodule such as the presence of calcification, cavitation or fat tissue density was evaluated. 
In addition, mediastinal lymph nodes bigger than 1 cm were also noted. 
 The second step of the study was the contrast enhanced scan. One of the widely used 
non-ionic iodinated contrast materials (Omnipaque®, Ultravist ®, Iomeron®,  Optiray® or 
Pamiray®) were given via the intravenous route. Contrast material amount was standardized 
according to the patient weight. 
 The nodules were re-scanned after contrast material injection at 1
st
, 2
nd
, 3
rd
, 4
th
, 5
th
, 
10
th
 and 15
th
 minutes, and the time versus enhancement curves were derived.  The maximum 
enhancement value was accepted as the “peak enhancement value”; the time for this value 
was named as the “peak enhancement time”. Pre-contrast density of the nodule was subtracted 
from the peak enhancement value to define the “maximum attenuation value”. The threshold 
value for maximum attenuation was set as 15 HU, and the nodules with maximum attenuation 
value above this level were accepted to be malignant. The results of this study were compared 
with histopathological diagnosis when tru-cut biopsy samples were available; otherwise 
follow-up CT and/or PET-CT results were used for comparison. Sensitivity and specificity 
values of the dynamic contrast enhanced CT were calculated according to the maximum 
attenuation threshold.  
 
FINDINGS 
 Thirty patients (F/M : 12/18) were enrolled in this prospective study. Twelve nodules 
(40 %) of the nodules in the study group were malignant, rest of the nodules (N=18, 60 %) 
were benign lesions. Nine patients in malignant group were men. The histopathological 
diagnosis of the malignant nodules were as follows: 5 adenocarcinoma (41 %), 3 non-small 
cell undifferentiated cancers (35 %), 1 carcinoid (8 %), 1 squamous cell cancer (8 %), 1 clear 
cell carcinoma (8 %) and 1 epithelial cancer metastasis (8 %). Age of the patients ranged 
between 29-82 years. Median age of the malignant patients was 68 years (25
th
 percentile: 65 
years – 75th percentile: 73 years). Median age of the patients with benign lesions was 59 years 
(25
th
 percentile: 46 years – 75th percentile: 75 years). No statistical difference was found 
between the median age of benign or malignant patients (p=0.305). 
 No statistical significant difference was present for gender of the patients and the 
location of the nodules between malignant and benign groups (p= 0,121 and p=0,611, 
respectively). On the other hand, diameter and the maximum attenuation values of the 
malignant nodules were significantly higher than the benign nodules (p= 0,039 and p=0,045, 
respectively). Median diameter of the malignant nodules was 2.5 cm (25
th
 percentile: 2.0 cm – 
75
th
 percentile: 2,87 cm), median diameter of benign nodules was 1,6 cm (25
th
 percentile: 1,3 
cm – 75th percentile: 2,4 cm). Median value of  peak enhancement  time was 2,5 minutes for 
malignant nodules (25
th
 percentile: 1,25  minutes – 75th percentile: 3,75 minutes) and 5 
minutes for benign nodules (25
th
 percentile: 2  minutes – 75th percentile: 5 minutes). 
 First of all, the average density values calculated for consecutive scans were 
compared to each other. The difference between the pre-contrast scan and all the post-contrast 
consecutive scans for malignant nodules were statistically significant (p<0,005). A similar 
difference was present between the 4
th
 and 5
th
 minute scans and the 15
th
 minute scan as well 
(p=. Also the post-contrast average densities for benign lesions were statistically significantly 
higher than pre-contrast scan (p>0,005). There was not also a significant difference between 
the post-contrast 15
th
 minute and the pre-contrast scans of benign lesions, totally different 
than the malignant ones (p=0,086).  
 Sensitivity, specificity, positive and negative predictive values for this study 
according to the 15 HU threshold were 92 %, 50 %, 58 % and 90 %, respectively. 
 
 CONCLUSION 
 Dynamic contrast enhanced CT is a highly sensitive but not so specific test for the 
assessment of solitary pulmonary nodules. The test may aid in the diagnosis of the selected 
cases, if the malignant or benign discrimination is not possible clinically. 
 
Keywords: Solitary pulmonary nodule, dynamic contrast enhanced CT 
 
 
 
